Can Rivaroxaban and Edoxaban Be Used During Breastfeeding? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jignesh Patel, adding:
“Can edoxaban and rivaroxaban be prescribed for breastfeeding mothers? The New Horizons clinical trial
Postnatal VTE risk is high, yet many women find injectable low-molecular-weight heparin hard to tolerate.
This phase IV trial measured how two oral anticoagulants pass into breast milk.
Rivaroxaban transferred at low levels (milk:plasma ratio 0.2), while edoxaban mirrored maternal plasma (ratio 0.9).
Modeling predicted low infant exposure for both, with the evidence favoring rivaroxaban as breastfeeding-compatible.”
Title: Can edoxaban and rivaroxaban be prescribed for breastfeeding mothers? The New Horizons clinical trial
Authors: Jignesh Patel, Andrew J. Butler, Giula Mackina, Sinead Duffy, Juliet Scarlett, Jane Alcazar, Loreena Bacarro, Obianuju Nzelu, Hua Xu, Nina Ince, Lewis Couchman, Evangelia Vlachodimitropoulou, Roopen Arya
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention